Mednote
MedNote is a company dedicated to providing integrated services in prevention and oncological therapeutic management. It offers a full-service approach for analysis, research, and development of new therapeutic strategies for tumor pathologies, supporting clinical research, data analysis, protocol development, ethical committee relations, and regulatory practices. The company collaborates with various academic and medical institutions to advance oncological research and personalized medicine.
Industries
Nr. of Employees
small (1-50)
Products
Mobile health application for therapy management
A patient-facing mobile application for remote therapy management and data collection available through major mobile app stores.
Smartphone PPG-derived digital biomarker models
Validated models and neural-network-based classifiers/regressors that use smartphone-acquired photoplethysmography waveforms to detect prevalent diabetes and estimate blood glucose levels in study cohorts.
PDE-based tumor response prediction model
Reactive–diffusive partial differential equation model implemented to predict post-treatment FDG-PET SUVmax and derive parameters representing nominal drug efficiency and tumor malignancy.
Biobank infrastructure and annotated specimen collections
Cryopreserved collections of human biospecimens with associated clinical annotation, managed for distribution to research projects.
Mobile health application for therapy management
A patient-facing mobile application for remote therapy management and data collection available through major mobile app stores.
Smartphone PPG-derived digital biomarker models
Validated models and neural-network-based classifiers/regressors that use smartphone-acquired photoplethysmography waveforms to detect prevalent diabetes and estimate blood glucose levels in study cohorts.
PDE-based tumor response prediction model
Reactive–diffusive partial differential equation model implemented to predict post-treatment FDG-PET SUVmax and derive parameters representing nominal drug efficiency and tumor malignancy.
Biobank infrastructure and annotated specimen collections
Cryopreserved collections of human biospecimens with associated clinical annotation, managed for distribution to research projects.
Services
End-to-end support for clinical studies including protocol development, data collection systems, ethics committee interactions, regulatory paperwork and study reporting; operations performed in collaboration with CRO partners.
Collection, cryopreservation, long-term storage and controlled distribution of annotated human biospecimens with consent management and data protection measures.
Design and delivery of clinical data collection platforms and patient-facing mobile applications for remote monitoring and therapy support.
Educational courses and training materials focused on digital therapy, tele-oncology and related clinical topics.
End-to-end support for clinical studies including protocol development, data collection systems, ethics committee interactions, regulatory paperwork and study reporting; operations performed in collaboration with CRO partners.
Collection, cryopreservation, long-term storage and controlled distribution of annotated human biospecimens with consent management and data protection measures.
Design and delivery of clinical data collection platforms and patient-facing mobile applications for remote monitoring and therapy support.
Educational courses and training materials focused on digital therapy, tele-oncology and related clinical topics.
Expertise Areas
- Clinical trial management and CRO operations
- Translational oncology research
- Digital health and mobile health applications
- Biobanking and biospecimen management
Key Technologies
- Photoplethysmography (PPG)
- Deep neural networks
- Machine learning regression (PLS, SVR, PCR, Random Forest)
- Signal preprocessing and feature extraction
News & Updates
A study analyzing the expression of PD-L1 and CD3 in glioblastoma patients and its correlation with clinical outcomes.
A biobank facility for the collection, preservation, and distribution of human biological materials and associated data for research.
An article discussing the current role of Abemaciclib in the treatment of metastatic breast cancer.
A scientific review on the inhibition of BRAF signaling in glioblastoma and its clinical implications.
Research on a non-invasive digital biomarker for diabetes detection using smartphone photoplethysmography.
Study on immune biomarkers in glioblastoma and their relation to patient outcomes.
A study analyzing the expression of PD-L1 and CD3 in glioblastoma patients and its correlation with clinical outcomes.
A biobank facility for the collection, preservation, and distribution of human biological materials and associated data for research.
An article discussing the current role of Abemaciclib in the treatment of metastatic breast cancer.
A scientific review on the inhibition of BRAF signaling in glioblastoma and its clinical implications.
Research on a non-invasive digital biomarker for diabetes detection using smartphone photoplethysmography.
Study on immune biomarkers in glioblastoma and their relation to patient outcomes.